South African and international markets closed on a positive note Thursday, marking a recovery after a volatile start to the week [1].
This rebound signals a stabilization of investor sentiment across local and global exchanges after several days of unpredictable trading patterns. The recovery suggests that market participants are regaining confidence in the face of earlier instability.
An eNCA Business anchor said that local and international markets closed on a positive note marking recovery following a volatile start to the week [1]. This upward trend coincided with specific corporate successes in the technology and pharmaceutical sectors.
AEM shares closed 18.7% higher [2]. This surge followed a report that the company's first-quarter net profit quadrupled to S$14.3 million [2].
In the pharmaceutical sector, Corvus Pharmaceuticals scheduled an investor and analyst meeting for 1:30 p.m. ET on May 14, 2026 [3]. The meeting focused on data from a Phase 1 clinical trial of soquelitinib for atopic dermatitis. Corvus Pharmaceuticals said the data includes new immunologic, and biomarker data supporting drug-free remissions [3].
The collective movement across these sectors reflects a broader trend of recovery for the day. While the week began with volatility, the closing figures for both South African and global indices indicate a shift toward positive territory [1].
“Local and international markets closed on a positive note marking recovery following a volatile start to the week.”
The simultaneous recovery of the South African and global markets indicates that the volatility seen earlier this week was likely a short-term correction rather than a systemic downturn. The strong performance of individual stocks like AEM and the anticipation of clinical data from Corvus Pharmaceuticals suggest that sector-specific growth is currently driving the broader market rebound.
